Metabol KLINIK s.r.o.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Chronic kidney disease2 trials
• Type 2 diabetes2 trials

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company3 trials
• Boehringer Ingelheim1 trial
• Novo Nordisk A/S1 trial

Running trials

• Recruiting

  A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  NCT07415954· Phase 2· Novo Nordisk A/S· Source

• Active, not recruiting

  A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT05869903· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source